AGP Executive Report
Last update: 9 hours agoCardiovascular Breakthrough (Australia): The STAREE trial presented at ESC 2026 found atorvastatin cut major cardiovascular events by 30% in adults aged 70+ without known heart disease, diabetes or dementia, but it didn’t significantly improve disability-free survival—an important nuance for primary prevention in older Australians. Cancer Access (Australia): The PBS expanded subsidised pembrolizumab (Keytruda) for additional advanced cancers, including bile duct, ovarian and Merkel cell carcinoma, expected to help about 700 Australians a year with much lower out-of-pocket costs. Bone Health Gap (Australia): Research highlights that many older Australians don’t know their osteoporosis risk, with big shortfalls in understanding which exercises help bones and balance—pointing to groups needing targeted education. Digital Safety (Australia): Australians are being warned after recent cyberattacks on major health and consumer services, with criminals able to stitch together personal details across breaches using AI. Public Health & Animals: Scientists are investigating mass sardine deaths in South Africa, including whether a fish herpes virus could be involved; the virus is said to pose no known human health risk. Community & Recovery (Wellness): A story on how running can support sobriety and brain health, alongside another on a country singer’s nine-month alcohol-free milestone.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.